CIDRAP newsletters options
Researchers in Switzerland yesterday reported they detected the MCR-1 resistance gene in a single Escherichia coli isolate collected from samples of human urinary tract infections. The research appeared in the International Journal of Infectious Diseases.
Health officials didn't confirm news reports that Zika is transmitting in Miami Beach, but said they are probing 8 areas outside the known hot spot.
Another study pinpoints placental cells that Zika can infect, and a report from Brazil describes 2 cases linked to platelet transfusion.
After 9 days of no new cases, the Saudi Arabia Ministry of Health (MOH) today reported a new case of MERS-CoV infection.
No illnesses have been detected in the woman's coworkers who traveled with her to Miami or in her household contacts.
After five human cases of avian influenza A (H7N9) appeared in China earlier this month, the World Health Organization (WHO) has said that limited human-to-human transmission cannot be ruled out for some that are part of a family cluster. Three of the five recent cases in humans appear to be in a cluster, the WHO said today in a statement.
Deep genome sequencing of two autopsy specimens from people who died in a 1979 accident at a Soviet anthrax production facility revealed that the Bacillus anthracis is similar to a wild type strain from Russia and shows no evidence of genetic manipulation for drug resistance or other characteristics.
Suspected cases have been reported in Brazzaville in the Republic of Congo, but none have been confirmed.
Patients infected with the Ebola virus were 20% more likely to survive if they were co-infected with malaria, according to a study of Liberians who received care at a treatment center in Monrovia in 2014 and 2015 during West Africa's outbreak. A research team led by the National Institute of Allergy and Infectious Diseases (NIAID) published the findings yesterday in Clinical Infectious Diseases.
In another key development, HHS recently declared a public health emergency for Zika virus in Puerto Rico.
Two more Michigan county fairs, one in Cass County and one in Ingham County, are reporting variant H3N2 (H3N2v) influenza in pigs, according to a media release from the Van Buren/Cass District Health Department. No ill human contacts have been reported, according to state health officials.
Infectious disease doctor Daniel Lucey, MD, MPH, penned an open letter to Director-General Margaret Chan, MD, MPH, of the World Health Organization (WHO), suggesting that the WHO reconsider declaring a Public Health Emergency of International Concern (PHEIC) over yellow fever cases in the Democratic Republic of the Congo (DRC) and the possibilities of an outbreak in the Republic of the Congo.
In another development, UK health officials warned travelers about an uptick in cases linked to Mexico, particularly the Riviera Maya coast.
Cases in Puerto Rico topped 10,000, as more countries and regions reported local spread, microcephaly, and GBS.
Two new variant H3N2 (H3N2v) influenza cases have been reported in Ohio, both of them in people who had contact with pigs at agricultural fairs, the Centers for Disease Control and Prevention (CDC) said today in its weekly flu update. The report also notes two H3N2v cases that were reported in Michigan a week ago.
A study of recent human and swine cases of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) in Norway noted that occupational exposure, trade of pigs, and livestock transport vehicles were common routes of transmission.
Yellow fever has declined in Angola, with no confirmed cases reported since June, but the disease in the Democratic Republic of the Congo (DRC) is spreading to new provinces and new parts of already affected provinces, the World Health Organization (WHO) said today in a weekly update.
Two reports today detail evidence of rising antibiotic-resistant Shigella among men who have sex with men.
HHS Secretary Burwell says lack of congressional action forced $81 million to be taken from other programs.
SAB Biotherapeutics, Inc., of Sioux Falls, S.D., announced today that its experimental human antibody treatment for MERS-CoV—called SAB-301—has entered human trials, the first potential treatment for the disease to do so.
